XML 51 R39.htm IDEA: XBRL DOCUMENT v3.4.0.3
INTANGIBLE ASSETS, NET (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Finite-Lived Intangible Assets    
Accumulated Amortization $ (157,315) $ (146,081)
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 1,851,861 1,761,332
Net Amount 1,694,546 1,615,251
Hormone therapy drug candidate patents - (pending) [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 787,149 774,165
Net Amount 787,149 774,165
Multiple trademarks for vitamins/supplements [Member]    
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 161,241 157,721
Net Amount 161,241 157,721
OPERA software patent [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 31,951 31,951
Accumulated Amortization (4,993) (4,493)
Net Amount $ 26,958 $ 27,458
Weighted average remaining amortization period 13 years 6 months 13 years 9 months
Development costs for corporate website [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount $ 91,743 $ 91,743
Accumulated Amortization $ (91,743) $ (91,743)
Net Amount
Approved Hormone Therapy Drug Candidate Patents [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount $ 779,777 $ 705,752
Accumulated Amortization (60,579) (49,845)
Net Amount $ 719,198 $ 655,907
Weighted average remaining amortization period 16 years 9 months 17 years